92527 ⎘
Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being unsaturated and containing six-membered aromatic rings
Sub-classes:COMPOSITIONS OF MATTER FROM UNSATURATED NITRILES
#2PHARMACEUTICAL SALT OF FINGOLIMOD, PREPARATION METHOD, PHARMACEUTICAL COMPOSITION AND USE THEREOF
#3POLYMORPHIC FORMS OF (R)-2-HYDROXY-2-METHYL-4-(2,4,5-TRIMETHYL-3,6-DIOXOCYCLOHEXA-1,4-DIENYL)BUTANAMIDE
#4HETEROCYCLIC COMPOUNDS AS IMMUNOMODULATORS
#5NOVEL 9H-FLUORENE DERIVATIVES OR THEIR PHARMACEUTICALLY ACCEPTABLE SALTS
#6TRNA SYNTHETASE INHIBITORS
#7Polymorphic forms of (R)-2-hydroxy-2-methyl-4-(2,4,5-trimethyl-3,6-dioxocyclohexa-1,4-dienyl)butanamide
#8PHOTOPROTECTIVE MIXTURES AS IMAGING REAGENTS IN SEQUENCING-BY-SYNTHESIS
#9Sphingosine kinase Type 1 inhibitors and uses thereof
#10TRNA synthetase inhibitors
#11Polymorphic and amorphous forms of (R)-2-hydroxy-2-methyl-4-(2,4,5-trimethyl-3,6-dioxocyclohexa-1,4-dienyl)butanamide
#12Application of Mannich base in flame-retardant polyurethane material
#13Sphingosine kinase type 1 inhibitors and uses thereof
#14METHODS FOR DIFFERENTIATING PLURIPOTENT CELLS
#15Methods and intermediates for synthesizing SK1-I
#16Sphingosine kinase type 1 inhibitors and uses thereof
#17Nitrated hydrocarbons, derivatives, and processes for their manufacture
#18Polymorphic and amorphous forms of (R)-2-hydroxy-2-methyl-4-(2,4,5-trimethyl-3,6-dioxocyclohexa-1,4-dienyl)butanamide
#19NEW PROCESS FOR EARLY SACUBITRIL INTERMEDIATES
#20Methods and intermediates for synthesizing SK1-I
#21Modulators of ATP-binding cassette transporters
#22Sphingosine kinase type 1 inhibitors and uses thereof
#23Sphingosine kinase type 1 inhibitors and uses thereof
#24Photoprotective mixtures as imaging reagents in sequencing-by-synthesis
#25Nitrated hydrocarbons, derivatives, and processes for their manufacture
#26Method of electrochemically modifying surface of electrode using dopamine-hyaluronic acid conjugates
#27Methods for differentiating pluripotent cells
#28Polymorphic and amorphous forms of (R)-2-hydroxy-2-methyl-4-(2,4,5-trimethyl-3,6-dioxocyclohexa-1,4-dienyl)butanamide
#29Sphingosine kinase type 1 inhibitors and uses thereof
#30Fingolimod hydrochloride process
#31SYNTHESIS OF BIPHENYLALANINOL VIA NOVEL INTERMEDIATES
#32Nitrated hydrocarbons, derivatives, and processes for their manufacture
#33Inhibiting neurotransmitter reuptake
#34Alkynyl phenyl derivative compounds for treating ophthalmic diseases and disorders
#35Methods for making oxetan-3-ylmethanamines
#36LIQUID FORMULATIONS
#37Alkynyl phenyl derivative compounds for treating ophthalmic diseases and disorders
#38Process for preparation of fingolimod
#39Modulators of ATP-binding cassette transporters
#40Amine derivative compounds for treating ophthalmic diseases and disorders
#41Synthesis of R-biphenylalaninol
#42Preparation of fingolimod and its salts
#43ALKYNE DERIVATIVES AS SPHINGOSINE 1-PHOSPHATE (S1P) RECEPTOR MODULATORS
#44LIQUID FORMULATIONS
#45Process for the production of 2-amino-2[2-(4-C2-20-alkyl-phenyl)ethyl]propane-1,3-diols, and to compounds for use therein
#46Isolated compounds from turmeric oil and methods of use
#47Organic Compounds
#48Aminoalkanol derivatives
#49Fingolimod polymorphs and their processes
#50Sphingosine kinase type 1 inhibitors
#51Amine, carboxylic acid flux composition and method of soldering
#52Modulators of ATP-binding cassette transporters
#53Alkynyl phenyl derivative compounds for treating ophthalmic diseases and disorders
#54Alkynyl phenyl derivative compounds for treating ophthalmic diseases and disorders
#55LIQUID FORMULATIONS
#56Benzyl amines, a process for their production and their use as anti-inflammatory agents
#57Use of ruthenium complexes for formation and/or hydrogenation of amides and related carboxylic acid derivatives
#58FTY720 HALOGENATED DERIVATIVES
#59Sphingosine kinase type 1 inhibitors, and processes for using same
#60Process for producing fingolimod salts
#61DEUTERATED FINGOLIMOD
#62Amine derivative compounds for treating ophthalmic diseases and disorders
#63Amine derivative compounds for treating ophthalmic diseases and disorders
#64Alkynyl phenyl derivative compounds for treating ophthalmic diseases and disorders
#65Benzyl, amines, a process for their production and their use as anti-inflammatory agents
#66Organic compounds
#67Organic compounds
#68Bicyclic sphingosine 1-phosphate analogs
#69Diamino-alcohol compounds and processes for their manufacture
#70Alanine racemase chiral binaphthol derivative with powerful hydrogen bond donor, and optical resolution and optical transformation methods using the same
#71Nitrated hydrocarbons, derivatives, and processes for their manufacture
#72Process for the production of 2-amino-2-[2-(4-C-alkyl-phenyl)ethyl]propane-1,3-diols, and to compounds for use therein
#73Process for the preparation of substantially pure (2S,3S,5S)-5-amino-2-N,N-dibenzylamino-3-hydroxy-1,6-diphenylhexane
#74Cyclic hydrocarbon compounds for the treatment of diseases
#75SUBSTITUTED ACETYLENIC COMPOUNDS USEFUL FOR THE TREATMENT OF DISEASES
#76Sphingosine kinase type 1 inhibitors, and processes for using same
#77AMINE COMPOUNDS AND INHIBITING NEUROTRANSMITTER REUPTAKE
#78Method for producing alcohol by hydrogenating lactone and carboxylic acid ester in liquid phase
#79Sphingosine kinase type 1 inhibitors, compositions and processes for using same
#80Modulators of ATP-binding cassette transporters
#81Amine derivative compounds for treating ophthalmic diseases and disorders
#82Substituted hydroxyethylamine aspartyl protease inhibitors
#83Modulators of ATP-binding cassette transporters
#84PROCESS FOR THE DEPROTECTION OF PROTECTED AMINES
#85Process for the preparation of (R)-(−)-3-(carbamoylmethyl)-5-methylhexanoic acid and of pregabalin and synthesis intermediates
#86Deuterated fingolimod
#87Compounds to treat alzheimer's disease
#88Alkynyl phenyl derivative compounds for treating ophthalmic diseases and disorders
#89BICYCLIC SPHINGOSINE 1-PHOSPHATE ANALOGS
#90Alanine racemase chiral binaphthol derivative with powerful hydrogen bond donor, and optical resolution and optical transformation methods using the same
#91PROCESSES AND INTERMEDIATES FOR THE PREPARATION OF HETEROCYCLIC SULFONAMIDE COMPOUNDS
#92AMINE COMPOUNDS AND INHIBITING NEUROTRANSMITTER REUPTAKE
#931-amino linked compounds
#94Phenyl-Pyrazole Derivatives as Non-Steroidal Glucocorticoid Receptor Ligands
#95Liquid Formulations
#96Aminoalkanol Derivatives
#97Arylamino-arylpropanolamine derivatives and methods of their use
#98Optically active bisoxazoline compounds, process for production of the same and use thereof
#99Optically active bisoxazoline compounds, process for production of the same and use thereof
#100Modulators of ATP-binding cassette transporters
#101Concise β-amino acid synthesis via organocatalytic aminomethylation
#102Androgen Receptor Modulators
#103Ceramides and apoptosis-signaling ligand
#104Benzyl amines, a process for their production and their use as anti-inflammatory agents
#105Hydroxypropylaimines
#106Novel process and intermediates 085
#107AMINE COMPOUNDS AND INHIBITING NEUROTRANSMITTER REUPTAKE
#108Method for producing optically active alcohols or carboxylic acids
#109Production method of aminochlorohydrin sulfate
#110Method for producing chiral or enantiomer-enriched beta-amino acids, aldehydes, ketones and gama-amino alcohols
#111Cyclic sulfone containing retroviral protease inhibitors
#112Methods of preparing retroviral proteases inhibitor intermediates
#113Compounds for the treatment of Alzheimer's disease
#114Binaphthol derivatives and their use in optical resolution or optical transformation
#115Amino-propanol derivatives
#116Optically active bisoxazoline compounds, process for production of the same and use thereof
#117Compounds active at a novel site on receptor-operated calcium channels useful for treatment of neurological disorders and diseases
#118Compositions that bind antiterminator RNA and assay for screening for such compositions
#119Production of 2-amino-2-(4-alkylphenyl)ethyl]propane-1,3-diols
#120N-protected/N-substituted-beta-amino hydroxy sulfonates
#121Modulators of ATP-binding cassette transporters
#122Process for producing optically active β-amino alcohol
#123Substituted urea and carbamate, phenacyl-2-hydroxy-3-diaminoalkane, and benzamide-2-hydroxy-3-diaminoalkane aspartyl-protease inhibitors
#124Substituted hydroxyethylamine aspartyl protease inhibitors
#125Amine compounds and inhibiting neurotransmitter reuptake
#126Compounds to treat Alzheimer's disease
#127Method of preparing intermediates useful in synthesis of retroviral protease inhibitors
#128Method of preparing retroviral protease inhibitor intermediates